Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes

• Margarite D. Matossian,

  Affiliation Department of Medicine: Section of Hematology and Oncology, Tulane University, New Orleans, Louisiana, United States of America

  http://orcid.org/0000-0002-9527-1043

  ⨯
• Steven Elliott ,

  Contributed equally to this work with: Steven Elliott, Van T. Hoang, Hope E. Burks, William J. Zuercher, David H. Drewry, Carrow Wells, Bridgette Collins-Burow, Matthew E. Burow

  Affiliation Department of Medicine: Section of Hematology and Oncology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Van T. Hoang ,

  Contributed equally to this work with: Steven Elliott, Van T. Hoang, Hope E. Burks, William J. Zuercher, David H. Drewry, Carrow Wells, Bridgette Collins-Burow, Matthew E. Burow

  Affiliation Department of Medicine: Section of Hematology and Oncology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Hope E. Burks ,

  Contributed equally to this work with: Steven Elliott, Van T. Hoang, Hope E. Burks, William J. Zuercher, David H. Drewry, Carrow Wells, Bridgette Collins-Burow, Matthew E. Burow

  Affiliation Department of Medicine: Section of Hematology and Oncology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Theresa B. Phamduy ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Physics, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Douglas B. Chrisey ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Physics, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• William J. Zuercher ,

  Contributed equally to this work with: Steven Elliott, Van T. Hoang, Hope E. Burks, William J. Zuercher, David H. Drewry, Carrow Wells, Bridgette Collins-Burow, Matthew E. Burow

  Affiliation Eshelman School of Pharmacy, University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• David H. Drewry ,

  Contributed equally to this work with: Steven Elliott, Van T. Hoang, Hope E. Burks, William J. Zuercher, David H. Drewry, Carrow Wells, Bridgette Collins-Burow, Matthew E. Burow

  Affiliation Eshelman School of Pharmacy, University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Carrow Wells ,

  Contributed equally to this work with: Steven Elliott, Van T. Hoang, Hope E. Burks, William J. Zuercher, David H. Drewry, Carrow Wells, Bridgette Collins-Burow, Matthew E. Burow

  Affiliation Eshelman School of Pharmacy, University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Bridgette Collins-Burow ,

  Contributed equally to this work with: Steven Elliott, Van T. Hoang, Hope E. Burks, William J. Zuercher, David H. Drewry, Carrow Wells, Bridgette Collins-Burow, Matthew E. Burow

  Affiliation Department of Medicine: Section of Hematology and Oncology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Matthew E. Burow

  Contributed equally to this work with: Steven Elliott, Van T. Hoang, Hope E. Burks, William J. Zuercher, David H. Drewry, Carrow Wells, Bridgette Collins-Burow, Matthew E. Burow

  * E-mail: mburow@tulane.edu

  Affiliation Department of Medicine: Section of Hematology and Oncology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯